logo

Deciphera Pharmaceuticals, Inc. (DCPH)



Trade DCPH now with
  Date
  Headline
11/30/2021 8:39:21 AM Deciphera Pharma To Reduce About 35% Or About 140 Positions
11/22/2021 7:06:55 AM Deciphera Pharma Gets European Commission Approval Of QINLOCK For Fourth-Line Gastrointestinal Stromal Tumor
11/5/2021 7:28:50 AM Deciphera Pharma Says INTRIGUE Phase 3 Clinical Study Of QINLOCK Did Not Meet Primary Endpoint
10/12/2021 7:08:51 AM Deciphera Pharma : Swissmedic Approves QINLOCK To Treat Fourth-Line Gastrointestinal Stromal Tumor
10/7/2021 9:17:34 AM Deciphera Presents Preclinical Data From DCC-3116 Program On Molecular Targets And Cancer Therapeutics
9/17/2021 8:20:51 AM Deciphera Receives Positive CHMP Opinion For QINLOCK For Treatment Of Fourth-line Gastrointestinal Stromal Tumor
2/3/2021 7:16:58 AM Veracyte To Acquire Decipher Biosciences For Total Consideration Of $600 Mln
1/11/2021 7:17:56 AM Deciphera Pharma Provides Corporate Update And Highlights Key 2021 Corporate Milestones
11/11/2020 7:23:29 AM Deciphera Presents Updated Preliminary Data From DCC-3014 At CTOS Meeting
11/11/2020 7:17:46 AM Deciphera Presents Data From QINLOCK Program At CTOS 2020 Virtual Annual Meeting
9/18/2020 7:06:49 AM Deciphera Announces Presentation Of Nine Month Follow-up Data from Phase 3 INVICTUS Study Of QINLOCK
7/20/2020 7:40:23 AM Zai Lab And Deciphera Pharma: China NMPA Accepts NDA For Ripretinib For Advanced Gastrointestinal Stromal Tumor
6/8/2020 7:33:36 AM Deciphera Reports Publication Of The INVICTUS Pivotal Phase 3 Study Of QINLOCK In The Lancet Oncology
5/29/2020 8:12:05 AM Deciphera Pharma Presents Preliminary Data From Phase 1b/2 Study Of Rebastinib With Paclitaxel At ASCO 2020
2/13/2020 10:40:35 PM Deciphera Pharma Prices Public Offering Of 3.18 Mln Shares At $55/Shr